SOURCE: IBC Life Sciences

January 08, 2008 08:30 ET

IBC's 20th International Antibody Development & Production Conference to Be Held This March

WESTBOROUGH, MA--(Marketwire - January 8, 2008) - IBC's Antibody Development and Production is being held on March 12-14, 2008 at the Sheraton San Diego Hotel & Marina in San Diego, CA. It is regarded by the industry as a leading resource for process development scientists and engineers looking for the latest case studies showcasing the most recent breakthroughs to help increase process efficiency and productivity. For more than 16 years and 20 conferences, IBC has shared a unique partnership with industry experts delivering programs that present solutions to the ongoing challenges of developing and producing antibody-based therapeutics.

Each year this event continues to evolve and explore new ways to accelerate speed to market and reduce cost with successful approaches to shortening timelines and streamlining workflows during early and late stage development. This is the industry's only comprehensive single-track event with best practices across the spectrum, including the most critical stages of upstream and downstream processing.

2008 Keynote Presentations:

--  From Gene to First Patient -- Proposal for Standardizing Metrics when
    Benchmarking Process Development
    Wolfgang Berthold, Ph.D., Chief Technical Officer, Technical Development,
    Biogen Idec
--  What are Therapeutic Antibodies Going to Look Like in the Future?
    William R. Strohl, Executive Director, Biologics Research, Merck Research
    Laboratories
--  Next Generation Immunotherapeutics -- Antibody-Conjugates, Antibody
    Fragments and Protein Scaffolds
    Rolf G. Werner, Ph.D., Professor, Senior Vice President, Corporate Division
    Biopharmaceuticals, Boehringer Ingelheim GmbH, Germany
--  Chromatography in MAb Processes -- Quo Vadis
    Greg Blank, Ph.D., Director, Late Stage Purification, Genentech, Inc.
    

This conference is conveniently scheduled following IBC's 12th International Process Validation for Biologicals, 3rd Annual Technology Transfer for Biopharmaceuticals and 4th Annual Outsourcing of Biopharmaceutical Manufacturing conferences, which will be held concurrently on March 10-11, 2008. Together, these four events provide you with a thorough, customized learning experience unmatched in the industry.

Additional Keynote Presentations at co-located events:

--  Quality by Design and Technology Transfers for Biopharmaceutical
    Products
    Anthony S. Lubiniecki, Vice President, Technology Transfer and Project
    Planning, Centecor R&D, Inc.
--  Challenges and Successes of Boehringer Ingelheim's CMO Strategy
    Rolf G. Werner, Ph.D., Professor, Corporate Senior Vice President,
    Biopharmaceuticals, Boehringer-Ingelheim, GmbH, Germany
    

ATTENTION CALENDAR EDITORS! For complete details on this event and the co-located conferences visit www.IBCLifeSciences.com/antibodyprod

Contact Information